Colgate-Palmolive Co (CL) Stock News

SpaceX began trading on Nasdaq on June 13, 2026, under ticker SPCX at an IPO price of $135 per share, achieving a valuation of approximately $1.77 trillion—reportedly the largest U.S. IPO by first-day market value. Defiance ETFs launched the Defiance Daily 2X Space ETF (SPCL), the first and only U.S. ETF offering 2X daily leveraged exposure to SpaceX Class A common stock on the IPO day.

Defiance ETFs announced the launch of Defiance Daily 2X Space ETF (SPCL) on Cboe, becoming the first and only U.S. ETF offering 2X daily leveraged exposure to SpaceX Class A shares on the company's IPO day. SpaceX priced its IPO at $135 per share, valuing the company at approximately $1.77 trillion, marking the largest IPO by opening day market cap in U.S. history. However, the article extensively warns of significant risks including leverage complexity, concentration risk, derivatives exposure, and SpaceX-specific risks related to Elon Musk's control and unproven technologies.

Defiance ETFs announced the launch of Defiance Daily 2X Space ETF (SPCL), the first U.S. ETF offering 2X daily leveraged exposure to SpaceX Class A shares on its IPO day. SpaceX priced its IPO at $135 per share, achieving a valuation of approximately $1.77 trillion, marking the largest IPO in U.S. history by market value on listing day. The ETF is designed for active traders and carries significant risks including daily rebalancing, concentration risk, and potential total loss of principal.

Defiance ETFs announced the launch of the Defiance Daily 2X Space ETF (SPCL), which provides 2x daily leveraged exposure to SpaceX Class A common stock on its IPO day. SpaceX priced its IPO at $135 per share, valuing the company at approximately $1.77 trillion, marking the largest IPO in U.S. history by market capitalization. The ETF is designed for active traders and carries significant risks including potential total loss of principal within a single trading day.

Defiance ETFs announced the launch of Defiance Daily 2X Space ETF (SPCL), which provides 2x daily leveraged exposure to SpaceX (SPCX) on its IPO day. SpaceX priced its IPO at $135 per share, valuing the company at approximately $1.77 trillion, making it the largest U.S. IPO by first-day market capitalization. The ETF is designed for active traders seeking short-term leveraged positions but carries significant risks including daily compounding effects, concentration risk, and potential total loss of principal.

Cboe BZX Exchange temporarily halted trading of the Defiance Daily 2X Space ETF (SPCL) at 10:45 A.M. EDT on June 12, 2026, due to significant market volatility surrounding SpaceX's initial public offering and the commencement of trading in SpaceX Class A common stock (SPCX) on Nasdaq. Trading is expected to resume no earlier than Monday, June 15, 2026. The fund's underlying portfolio assets remain secure during the halt.

WisdomTree's Christopher Gannatti argues that SpaceX's IPO presents a unique valuation challenge because the company operates across multiple business segments—rocket launches, satellite broadband (Starlink), and AI infrastructure—that don't fit neatly into existing categories. This complexity will likely create persistent disagreement among analysts about fair value, potentially generating both volatility and investment opportunities.

SpaceX may be strategically choosing not to prioritize profitability, instead reinvesting heavily in Starship and AI infrastructure to drive long-term growth. This mirrors Amazon's historical approach of accepting near-term losses for future opportunities. Experts argue the company could be profitable today if it reduced capital expenditures, but investors are willing to accept this strategy based on the company's ambitious vision.

Defiance ETFs announced that its Defiance Daily 2X Space ETF (SPCL) will provide 2X daily leveraged exposure to SpaceX Class A common stock, making it the first U.S. ETF with such exposure on SpaceX's IPO day. SpaceX priced its IPO at $135 per share, valuing the company at approximately $1.77 trillion, marking the largest U.S. IPO in history by debut market value.

As investors debate whether Space Exploration Technologies Corp’s (NASDAQ: SPCX ) blockbuster valuation can be justified, one space economy expert says they may be focusing on the wrong metric . The bigger story isn’t that SpaceX isn’t profitable. It’s that the company may be choosing not to be. “It’s the Amazon play,” Micah Walter-Range , co-developer of the VettaFi Space Index tracked by the Procure Space ETF Procure Space ETF (NASDAQ: UFO ) , told Benzinga in exclusive email interview. Profitability Vs. Growth SpaceX’s lack of profits has become a key talking point following its public debut. But Walter-Range argues the company could potentially improve its bottom line today if it were willing to slow some of its most ambitious projects. “Considering the recently announced revenue streams from data center capacity leases to Anthropic and Google , the AI side of the business could be profitable if it brings capex down to a level below revenue,” he said. The same logic applies to the ... Full story available on Benzinga.com

SpaceX is set to debut on public markets on June 12, 2026, with an IPO price of $135 per share, valuing the company at approximately $1.75 trillion. A Benzinga poll shows 87% of viewers expect the stock to open above the IPO price, citing strong demand exceeding available shares. However, 49% of respondents indicated they would not buy at valuations above $1.75 trillion.

Vivakor announced a joint venture with Monarch R&P Management to commission and operate its Houston-area Remediation Processing Center, with commercial operations expected in Q3 2026. The company also secured a one-year crude oil transaction for approximately 100,000 barrels per month through Cushing Terminal, valued at roughly $108 million annualized.

Cycurion (NASDAQ:CYCU) completed its acquisition of Secuvant on June 2, 2026, for approximately $2.875 million in cash and preferred shares, with potential earn-out payments through 2028. The deal aims to expand Cycurion's cybersecurity product portfolio and enhance recurring revenue solutions. However, the stock faces significant technical headwinds, trading near 52-week lows with a 94.11% decline over the past 12 months.

As Oracle Corp. (NYSE: ORCL ) approaches its fourth-quarter earnings report on June 10, the software giant presents a dichotomy: quantitative algorithms flag the stock as overpriced due to a plunging value score, yet Wall Street analysts at Guggenheim maintain massive conviction, projecting an 88.83% upside for what they dub their “Best Idea.” Benzinga Edge Valuation Flags ORCL As Overpriced Oracle’s stock is flashing warning signs, as the latest Benzinga Edge Stock Rankings show that the company’s value score fell to 12.45 week-on-week. The value score is a percentile-ranked composite metric that evaluates a stock’s relative worth by comparing its market price to fundamental measures of the company’s assets, earnings, sales, and operating performance. This sharp decline suggests that Oracle’s stock price, which closed 0.97% lower at $211.82 on Monday, has significantly outpaced its underlying fundamental metrics, causing it to screen as statistically overpriced. data-variant="card" data-news-mode="manual" > Read Also: Full story available on Benzinga.com

TCL SunPower stellt auf der SNEC in Shanghai und Intersolar Europe in München neue Solarmodule und Energiesysteme vor, die auf der nächsten Generation ihrer Back-Contact-Technologie basieren. Das Unternehmen präsentiert unter den Marken SunPower und TCL Solar integrierte Energielösungen für Privathaushalte sowie Gewerbe- und Industrieanwendungen, einschließlich neuer PV-Module mit Wirkungsgraden bis 24,7%, Speicherlösungen und intelligente Energiemanagementsysteme.

TCL SunPower announced its participation at SNEC and Intersolar Europe trade shows, where it will debut next-generation integrated energy systems featuring advanced back contact cell technology. The company will showcase innovations across its dual-brand strategy: SunPower for premium residential solutions and TCL Solar for commercial/industrial applications, including new solar modules, energy storage solutions, heat pumps, and AI-powered energy management platforms.

TCL SunPower announced its participation in SNEC and Intersolar Europe conferences, showcasing new energy solutions powered by next-generation back contact solar panel technology. The company presented innovations across both SunPower and TCL/TCL Solar brands, including high-efficiency solar modules (up to 24.7% efficiency), residential and commercial energy storage solutions, heat pumps, and an AI-powered energy management platform. The back contact technology reduces resistive losses, improves thermal performance, and offers industry-leading degradation rates and temperature coefficients.

A class action lawsuit has been filed against Helen of Troy Limited for allegedly misleading investors about Project Pegasus, a restructuring initiative. The company claimed the project was delivering efficiencies and cost savings, but in reality lacked sufficient resources and budget. When the truth emerged in July 2024, the company reported a 49% EPS decline and cut full-year revenue guidance by over 20%, causing stock to drop 27.7%. Investors who purchased shares between April 24, 2024, and October 8, 2025, can join the lawsuit.

HUHUTECH International Group Inc. announced that its subsidiary Tiger Technology has completed development and commercialization of the HB-800, a high-end vacuum furnace for MOCVD susceptor cleaning and precision heat-treatment applications. The launch marks the company's transition from a facility engineering services provider to an integrated solutions company with proprietary equipment, targeting semiconductor, photovoltaic, SiC/GaN materials, aerospace, and medical precision component markets. HUHU shares rose 6.87% in premarket trading.

Cullinan Therapeutics announced positive Phase 1 clinical data for CLN-978, a CD19xCD3 T cell engager, showing clinical benefit including remissions in both systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) patients following single target doses. The drug demonstrated deep, dose-dependent B cell depletion with a favorable safety profile. The company will present additional data and host an Immunology Day on June 10 to discuss CLN-978 and initial data for velinotamig, a BCMAxCD3 T cell engager.

Tidal Financial Group and Stoneport Advisors announced the planned closure and liquidation of the Stoneport Advisors Commodity Long Short ETF (SCLS). The fund will be delisted from Nasdaq on June 16, 2026, with liquidation completed by June 18, 2026. Shareholders can sell their shares in the secondary market before the closing date.

Wescan Goldfields Inc. (TSXV:WGF) has closed the first tranche of its non-brokered private placement, raising $2.24 million through the issuance of 10.2 million units at $0.22 per unit. Each unit includes one common share and one-half warrant exercisable at $0.35 for 24 months. The company plans to use proceeds to fund its 2026 summer exploration program at the Munro Lake Project in Saskatchewan, located near SSR Mining's Seabee Mine complex, following up on encouraging 2013 drill results.

Nature's Miracle Holding Inc. (NMHI) has entered into a Memorandum of Understanding with FF AI-Robotics Inc. to establish a strategic partnership supporting the launch and expansion of FF's Robotics Partnership Program across North America. Under the partnership, Nature's Miracle will develop a network of robotics facilities including showrooms, operation centers, and service centers, while taking delivery of 17 Aegis Pro and 6 Navi robots at its Chicago facility.

Vivakor (NASDAQ:VIVK) announced a one-year crude oil transaction through its commodities trading platform, involving approximately 100,000 barrels per month through the Cushing Terminal from June 2026 to May 2027, valued at an estimated $108 million annualized. The deal aims to expand the company's capabilities in sourcing, marketing, transporting, and managing crude volumes while improving asset utilization across its integrated operating network.

Tourmaline Oil Corp. announced a quarterly cash dividend of $0.50 per share payable on June 30, 2026, and held its annual shareholder meeting on June 3, 2026, where ten directors were elected. The company is Canada's largest natural gas producer focused on low-cost development in the Western Canadian Sedimentary Basin.

A class action lawsuit has been filed against Veritone, Inc. for allegedly making false statements and failing to disclose accounting irregularities during the period between October 14, 2025 and April 14, 2026. The company allegedly inaccurately recorded revenue and costs, overstated financial metrics, and maintained deficient internal controls, requiring a financial restatement.

VersaBank (NASDAQ: VBNK) announced a quarterly cash dividend of CAD $0.025 per common share, payable July 31, 2026, to shareholders of record as of July 10, 2026. The dividends are eligible for tax purposes.

Law firm Bragar Eagel & Squire is investigating Claritev Corporation following a DOJ criminal price-fixing investigation into the company's Data iSight pricing tool, reported by The Capitol Forum on May 14, 2026. The announcement triggered a sharp 41% stock price decline, dropping from $23.47 to $13.87 per share. The firm is seeking stockholders who suffered losses to discuss potential legal claims.

John Hancock Investment Management announced quarterly distributions for four closed-end funds on June 1, 2026. The funds declared distributions ranging from $0.1535 to $0.6500 per share, with payment scheduled for June 30, 2026. Distributions may include net investment income, capital gains, and return of capital.

John Hancock Investment Management announced monthly distributions for its closed-end funds on June 1, 2026. The Tax-Advantaged Dividend Income Fund (HTD) will distribute $0.1580 per share monthly, while the Premium Dividend Fund (PDT) will distribute $0.0825 per share monthly. All distributions are scheduled for payment on June 30, 2026.